A panelist discusses how a large propensity score–matched analysis of 1300 patients aged 60-75 found similar all-cause mortality between intensive chemotherapy and azacitidine plus venetoclax, but ...
Policymakers have grown increasingly interested in how experimental results may generalize to a larger population. However, recently developed propensity score–based methods are limited by small ...
Randomized trials remain the most accepted design for estimating the effects of interventions, but they do not necessarily answer a question of primary interest: will the programme be effective in a ...
The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy. We analyzed surveillance data on inpatients ...
Impact of Performance Status on Response and Survival Among Patients Receiving Checkpoint Inhibitors for Advanced Solid Tumors The health administrative data in Ontario, Canada, present a unique ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback